Asmacure Announces Top-Line Clinical Results for ASM-024 DPI in Ph 1/2a Trial

News - Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of novel, proprietary compounds that target cholinergic receptors for the treatment of pulmonary diseases, today announced top-line results from a combined Phase 1 and 2a trial evaluating its lead compound, ASM-024, in moderate asthma patients.

3Macs and Desjardins Securities reach collaboration agreement

News - 3Macs and Desjardins Securities, the brokerage firm of Desjardins Group, are pleased to announce a new agreement to work together to grow their businesses. The agreement includes the acquisition by 3Macs of three Ontario branches of Desjardins Securities as well as the transfer of their employees and clients. The transaction will also give 3Macs advisors access to Desjardins wealth management products and provide an opportunity for Desjardins to exercise a minority ownership interest in 3Macs in the coming year.

CO2 Solutions Partners with Neumann Systems for U.S. Pilot Demonstration of Carbon Capture Process

News - CO2 Solutions, an innovator in the field of enzyme-enabled carbon capture technology, today announced that it has entered into a Collaboration Agreement with Colorado-based Neumann Systems Group, Inc., an established emissions control solutions provider.

Industrial Alliance Obtains Authorization to Act as Administrator of a Voluntary Retirement Savings Plan (VRSP)

News - Industrial Alliance is pleased to announce that it has received authorization from the Autorité des marchés financiers (AMF) to act as administrator of a voluntary retirement savings plan (VRSP), the new retirement savings vehicle that will come into effect on July 1, 2014.

After the United States, the United Kingdom, Germany and France, Rooster doodle-doo is now in China!

News - Attraction Distribution is pleased to announce the sale of Rooster doodle-doo, the feature-length animation film from Quebec’s 10th Ave Productions, to China Movie Channel for airing on Chinese television. The film is the first feature-length animation film directed by Pierre Greco, and it is produced by Nancy Florence Savard of 10th Ave (The Legend of Sarila).

Government of Canada Hails Inauguration of New Facilities at Complexe de Soccer Honco de Lévis

News - Acting on behalf of the Honourable Denis Lebel, Minister of Infrastructure, Communities and Intergovernmental Affairs and Minister of the Economic Development Agency of Canada for the Regions of Quebec, Jacques Gourde, Member of Parliament for Lotbinière-Chutes-de-la-Chaudière and Parliamentary Secretary to the Prime Minister for Official Languages and for the Economic Development Agency of Canada for the Regions of Quebec, took part in today's official ceremony inaugurating the new facilities of the Complexe de soccer Honco de Lévis.

SGA chooses Québec City

News - The Québec City Convention Centre will welcome the Society for Geology Applied to Mineral Deposits (SGA) 14th Biennial Meeting from August 19 to 23, 2017. It is the first time that this international society will meet in North America.

New Canadian Flu Vaccine has entered Phase 1 Clinical Trial

News - The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a national Centre of Excellence for Commercialization and Research (CECR), and FOLIA BIOTECH Inc. in Quebec City are pleased to announce the initiation of an influenza vaccine Phase 1 clinical trial at the Canadian Center for Vaccinology in Halifax. This clinical study will be the first in human use of the novel PAL vaccine adjuvant.

CO2 Solutions Updates Composition of the Scientific Advisory Board

News - CO2 Solutions announces the new composition of its Scientific Advisory Board. The former Scientific Advisory Board was assembled in 2009. Those members of the Advisory Board have actively contributed to the scientific orientations and knowledge breadth of CO2 Solutions. Over the recent months, CO2 Solutions' technology has evolved rapidly and has now reached enough maturity to seriously delve into commercial opportunities.

Blood product sterilization taken too far?

News - Certain processes used to sterilize blood products could potentially cause serious health issues in transfusion recipients, according to an international study published in the journal Platelets and led by Dr. Patrick Provost of Université Laval’s Faculty of Medicine and the CHU de Québec Research Center. These processes purportedly alter the blood platelets to the extent of preventing them from carrying out their functions correctly and may be the cause of hemorrhages observed in patients having received treated blood.


Subscribe to our newsletter for interesting news and information.

Print this page